International Business Machine (NYSE:IBM) said it finished its $1 billion purchase of medical image and clinical systems company Merge Healthcare. Merge shareholders are slated to receive $7.13 per share in cash as the transaction closes, the Armonk, N.Y.-based company said. IBM said it will combine the newly purchased assets, including data and images from Merge Healthcare’s medical imaging […]
(Reuters) — International Business Machine (NYSE:IBM) said it would buy Merge Healthcare (NSDQ:MRGE), which provides medical images and clinical systems, in a $1 billion deal and combine it with its Watson Health analytics unit. Merge Healthcare shareholders will get $7.13 per share at a premium of 31.8% to yesterday’s close, the companies said. Merge Healthcare shares were up […]
Merge Healthcare (NSDQ:MRGE) said yesterday it formed a strategic partnership with Toshiba Medical Systems (TYO:6502) to offer both companies products together as a turnkey solution for customers. The companies will partner to offer Merge’s cardiology PACS and hemodynamic monitoring with the Toshiba vascular x-ray systems, Chicago, Ill.-based Merge Healthcare said. “For more than 15 years, the Toshiba […]
Shares of Becton Dickinson (NYSE:BDX) slipped 4.4 percent today after the company announced a 24.4 percent profit slide and missed Wall Street’s expectations for its Q4 earnings.
BD posted profits of $300.0 million, or $1.36 per share, on sales of $2.05 billion for the three months ended Sept. 30. That compares with profits of $396.7 million, or $1.68 per share, on sales of $1.87 billion during the same period last year.
MASSDEVICE ON CALL —Boston Scientific Corp. (NYSE:BSX) began seeking approval for a $41 building project in Ireland to house the neurovascular unit it sold to Stryker Corp. (NYSE:SYK) earlier this year.
The 100,000 square foot facility will live on Boston Scientific’s Cork, Ireland, campus but will be operated by Stryker, and some 600 local BSX employees will transfer to the new facility when it’s ready.
Orthopedic company Symmetry Medical (NYSE:SMA) signed a definitive agreement to acquire Olsen Medical the terms of which were not disclosed.
Olsen manufactures single-use and reusable forceps, cords, electrosurgical pens/pencils, electrodes and accessories sold primarily in the U.S. and internationally through distributors.
Mauna Kea Technologies is looking to raise up to $67 million through an initial public offering of 3.29 million shares on the NYSE Euronext stock exchange.
The offering will priced between 10.65 euros and 13 euros a share and is expected to close on July 4, according to Reuters news service .
Stryker Corp. (NYSE:SYK) agreed to pay $150 million in up-front cash for Memometal Technologies SA, plus another $12 million in milestone payments.
Bruz, France-based Memometal makes implants for the extremities using shape memory alloys. The $162 million value of the deal is a 5.4x multiple of the $30 million the company posted to its top line last year.
ImageIQ, a contract research organization specializing in image analysis for clients in the research, pharmaceutical and medical device industries, is the latest startup from Cleveland Clinic’s technology commercialization group.
CROs typically do development work for drug companies, helping screen drug candidates, perform animal testing and run clinical trials. Imaging CROs generally help drug and device firms, and research organizations analyze images they’ve collected in preclinical and clinical trials through technology such as MRIs or CT scans, for example.
With little more than a week to go before its $248 million deal to acquire Amicas Inc. (NSDQ:AMCS) is slated to close, Merge Healthcare Inc. (NSDQ:MRGE) extended its tender offer for Amicas shares through April 23.
Through the end of trading on April 15, shareholders controlling a combined 89.8 percent of Amicas stock had tendered their shares — just under the 90 percent goal the two medical information and image management companies set for tying a bow on their proposed merger.
Amicas Inc. (NSDQ:AMCS) jilted its erstwhile buyer, private equity firm Thoma Bravo LLC, in favor of a higher offer from Merge Healthcare Inc. (NSDQ:MRGE) that it initially met with disdain.